Acute respiratory distress syndrome: Difference between revisions
(Created page with "'''Acute respiratory distress syndrome''' (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe respiratory failure. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate. == Etiology == * Sepsis (most common) * Pneumonia * Aspiration of gastric content * Shock * Acute pancreatitis * Major trauma == Clinical features == * Dyspnoea, restlessness, anxiety * Altered mental status * Cyan...") |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
'''Acute respiratory distress syndrome''' (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe [[respiratory failure]]. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate. | <section begin="A&IC" />'''Acute respiratory distress syndrome''' (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe [[respiratory failure]]. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate. | ||
== Etiology == | == Etiology == | ||
Line 42: | Line 42: | ||
* [[ECMO]] – if all other methods of oxygenation fail | * [[ECMO]] – if all other methods of oxygenation fail | ||
* If due to COVID-19: [[Dexamethasone]] and [[tocilizumab]] | * If due to COVID-19: [[Dexamethasone]] and [[tocilizumab]] | ||
<section end="A&IC" /> | |||
[[Category:Intensive care]] | |||
[[Category:Pulmonology]] |
Latest revision as of 18:57, 27 October 2024
Acute respiratory distress syndrome (ARDS) is a life-threatening inflammation with oedema in the lungs which leads to severe respiratory failure. It occurs in approx. 10% of ICU patients, and there is a 50% mortality rate.
Etiology
- Sepsis (most common)
- Pneumonia
- Aspiration of gastric content
- Shock
- Acute pancreatitis
- Major trauma
Clinical features
- Dyspnoea, restlessness, anxiety
- Altered mental status
- Cyanosis
Diagnosis and evaluation
Diagnosis by the Berlin criteria. All four must be met:
- Respiratory failure within one week of a known cause of ARDS
- Bilateral opacities on x-ray or CT
- Hypoxaemia (decreased PaO2/FiO2)
- The degree of hypoxaemia determines whether it’s mild, moderate, or severe ARDS
- Heart failure or fluid overload does not account for the respiratory failure
Management
- Treat the underlying condition
- Supportive oxygen therapy (non-invasive ventilation)
- Non-invasive ventilation may be tried in mild-moderate ARDS, but 50% of patients require intubation later anyway
- Intubation and invasive ventilation should not be delayed
- Lung-protective mechanical ventilation (invasive ventilation)
- Lung-protective ventilation refers to changing the settings of the ventilator to protect the lung from barotrauma and volutrauma during invasive ventilation
- This means low tidal volume, low plateau pressure, and high positive end-expiratory pressure (PEEP)
- These settings cause hypercapnia but that’s not a problem and we allow it. This is called permissive hypercapnia
- Neuromuscular blockers if severe
- Cisatracurium
- Must be used early
- Prone positioning if moderate or severe
- Fluid overload should be avoided
- ECMO – if all other methods of oxygenation fail
- If due to COVID-19: Dexamethasone and tocilizumab